Forecasting disease progression
About us
We are an AI-driven precision medicine company developing a multimodal prognostic platform to forecast disease progression in age-related disorders. Our forecasts provide new tools to physicians for improved patient care and to pharmaceutical companies for faster drug development. Our current applications are in Alzheimer's disease and feature AD-Px™ prognostic engine.
Foresight™️ - Our Predictive Platform
Multimodal
Our platform can leverage multiple sources of data (imaging, genetic, phenotypic, molecular and clinical variables) to better characterize individuals.
High precision targeting
We are able to rapidly and precisely target subgroups of interest in large, heterogeneous populations.
Highly actionable insights
Our digital biomarkers are highly specific and thoroughly validated, making them ready for action in any clinical setting.
To learn more, visit our Publications page!
Latest News
Perceiv AI Partners with TheraVac Biologics to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers
January 13, 2025 | San Francisco, USA | Press release
Perceiv AI’s receives ADRIQ Innovation Award for its AI-powered multimodal prognostic platform to predict disease progression.
November 22, 2024 | Montreal, Canada | Press Release
The AD-Px™ prognostic model increases statistical power of early Alzheimer's disease clinical trials. New results presented at CTAD 2024.
October 30, 2024 | Clinical Trials on Alzheimer's Disease conference (CTAD) | Poster
Perceiv AI Welcomes Simona Skerjanec to Board of Directors
October 14, 2024 | Montreal, Canada | Press release
Perceiv AI Raises the Bar with ISO 27001 Certification
May 7, 2024 | Montreal, Canada | Press release
Perceiv AI Achieves HIPAA Compliance, Reinforcing Commitment to Data Security and Privacy
November 28, 2023 | Montreal, Canada | Press release
Perceiv AI is now a resident of JLABS Johnson & Johnson
June 21, 2023 | Toronto, Canada | Annoucement
Merck Selects Perceiv AI for Inaugural Digital Sciences Studio Cohort
January 17, 2023 | Boston, USA | Annoucement
Find all our past news and announcements in our Newsroom!
Meet our Team
Christian Dansereau, Ph.D.
CEO & Founder
César Laurent, Ph.D.
CTO & Founder
Angela Tam, Ph.D.
Senior Scientist
Adrián
Noriega de la Colina,
M.D., Ph.D.
Clinical and Regulatory Lead
Maxime Jacques, M.A.Sc
Software Engineer
Christine Newton, C.P.A.
VP Finance
Meet our Board of Directors
Simona Skerjanec, MBA
Richard H. Stark, M.S.
Christian Dansereau, Ph.D.
CEO & Founder
César Laurent, Ph.D.
CTO & Founder
Meet our Advisors
Yoshua Bengio, Ph.D.
Full Professor at Université de Montréal,
Founder and Scientific Director of Mila,
Scientific Director of IVADO
Serge Gauthier, M.D.
Full Professor at McGill University,
Director of the Alzheimer Disease and Related Disorders Research Unit, Douglas Research Centre
Richard H. Stark, M.S.
Physicist, Entrepreneur & Investor Former Executive at Varian, ViewRay and Elekta
Betsabeh Madani Hermann, M.B.A.
Healthcare executive & investor,
Global Head of Research
Investors
Our Partners
We have partnered with some of the most innovative actors in the business. A resident of JLABS Johnson & Johnson
Supported by
